Jacques G. Baillargeon, Ph.D.

Associate Professor

Department of Pediatrics

Cancer, obesity, adipokines, infectious disease, HIV/AIDS, epidemiologic methods

Publications:

Baillargeon J, Langevin A, Lewis M, Grady J, Thomas P, Mullins J, Estrada J, Pitney A, Sacks N, Pollock P. (2005).  Therapy-related changes in body size in Hispanic children with acute lymphoblastic leukemia.  Cancer, 103, 1725-1729

Baillargeon J, Langevin A, Mullins J, Ferry R, DeAngulo G, Thomas P, Estrada J, Pitney A, Pollock B. (2005). Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia.  Pediatric Blood & Cancer, (Feb 7, epub ahead of print).

Baillargeon J, Pollock B, Kristal A, Bradshaw P, Hernandez J, Basler J, Higgins B, Lynch S, Rozanski T, Troyer D, Thomspon I. (2005).  The association of body mass index and prostate specific antigen in a population-based study.  Cancer, 103, 1092-1095/

Kellogg N, Baillargeon J, Lukefahr J, Lawless K, Menard S. (2004)  Comparison of ligase chain reaction tests and cultures in the detection of chlamydia trachomatis and neisseria gonorrhea in suspected victims of child abuse. Journal of Pediatric and Adolescent Gynecology, 17, 331-339.

Baillargeon J, Kelley M, Leach C, Baillargeon G, Pollock B. (2004). Methicillin-resistant Staphylococcus aureus infection in the Texas prison system.  Clinical Infectious Disease, 38.

Baillargeon J, Black S, Leach C, Jenson H, Pulvino J, Bradshaw P, Murray O (2004)  The infectious disease profile of Texas prison inmates. Preventive Medicine, 38, 607-612.

*Infante I, Baillargeon J, Kraig E, Jackson C, Hammerling G, Raju R, David C. (2003)  Diverse human T cell receptor repertoire for acetylcholine receptor, the autoantigen of myasthenia gravis. Journal of Automimmunity, 21, 167-174.

Baillargeon J, Pollock B, Leach C, Gao S. (2004)  The association of neoplasms and HIV infection in the correctional setting.  International Journal of STD & AIDS, 5, 348-51

*Baillargeon J., Bradshaw P. (2003)  The association of infectious disease diagnoses with incareceration-related factors among prison inmates.  Journal of Correctional Health Care, 10, 15-34.

Falck A, Escobedo M, Baillargeon J, Villard L, Gunkel J. (2003)  The proficiency of pediatric residents in performing neonatal endotracheal intubation. Pediatrics, 112: 1242-1247

Baillargeon J, Ducate S, Pulvino J, Bradshaw P, Murray O, Olvera R. (2003).  The association of psychiatric disorders and HIV infection in the correctional setting.  Annals of Epidemiology, 13, 1-7.

Baillargeon J, Wu H, Kelley M, Grady J, Linthicum L, Dunn K. (2003)  Hepatitis C Seroprevalence among newly incarcerated inmates in the Texas correctional system.  Public Health, 117, 43-48.

Baillargeon J, Kelley M, Lichtenstein M, Jenson H. (2002). Management of tuberculosis in the Texas prison system.  Journal of Correctional Health Care, 9, 77-92.

Leach C, Ashley R, Baillargeon J, Jenson H. (2002) Performance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescents. Clin Diagn Lab Immunol, 9: 1124-1125.

Schaub RL, Reveles XT, Baillargeon J, Leach RJ, Cody JD. (2002) Molecular characterization of 18p deletions: identification of a breakpoint cluster. Genet Med, 4, 15-19.

Baillargeon J, Contreras S. (2001) Antipsychotic prescribing patterns in the Texas Prison system. Journal of the American Academy of Psychiatry and the Law, 29, 1-6.

Baillargeon J, Deng J, Hettler E, Harrison C, Grady J, Korte L, Alexander J, Montalvo E, Jenson H, Gao SJ. (2001) Seroprevalence of Kaposi's sarcoma-associated herpesvirus Infection among blood donors from Texas.  Annals of Epidemiology, 11: 512-518.

Wu ZH, Baillargeon J, Grady J, Black S, Dunn K. (2001)  HIV seroprevalence among newly incarcerated inmates in the Texas Correctional System.  Annals of Epidemiology, 11 (5): 342-6.

Baillargeon J, Linton A, Black S, Zepeda S, Grady J.  (2001)  Medication prescribing and adherence patterns among prison inmates with diabetes mellitus.  Journal of Correctional Health Care , 8, 37-53

Baillargeon J, Black S, Contreras S, Grady J, Pulvino J (2001). Antidepressant prescribing patterns for prison inmates with depressive disorders.  Journal of Affective Disorders, 63, 225-231.

Demirci CS, Miller DR, Baillargeon J, Moyer MP, Jenson HB. (2001) Smokeless tobacco extracts modulate exogenous gene expression in early passage cultured human oral epithelial cells: an in vitro system to study chemical and viral enhancer/promoter interaction.  Journal of Pharmacological and Toxicological Methods, 44, 527-532.

Zhang YJ, Wang XP, Deng JH, Davis T, Baillargeon J, Yeh T, Jenson H, Gao SJ. (2001).  Distinct distribution of rare US KSHV genotypes in South Texas: implications for KSHV epidemiology.  The Journal of Infectious Disease, 183, 125-129.

Kelly P, Bair R, Baillargeon J. (2000) Risk behaviors and the prevalence of chlamydia in a predominantly Hispanic juvenile detention center. Journal of Clinical Pediatrics  September, 521-527.

Baillargeon J, Borucki M, Zepeda S, Jenson H, Leach C. (2000) Antiretroviral prescribing patterns in the Texas prison system.  Clinical Infectious Disease, 31, 1,476-81.

Baillargeon J, Black S., Pulvino J, Dunn K. (2000)  The Disease Profile of Texas Prison Inmates.  Annals of Epidemiology, 10: 74-80.

Hale D, Cody J, Baillargeon J, Schaub R, Danney M, Leach R. (2000)  The spectrum of growth abnormalities in children with 18q deletions.  The Journal of Clinical Endocrinology and Metabolism, 85: 4,450-4,454.

Baillargeon J, Piper J, Leach C. (2000) Epidemiology of Herpesvirus 6 (HHV-6) Infection in pregnant and nonpregnant women.  Journal of Clinical Virology, 16: 149-157.

Baillargeon J, Contreras S, Grady J, Black S, Murray O.  (2000).  Compliance with antidepressant medication among prison inmates with depressive disorders.  Psychiatric Services, 51, 1444-1446.

Baillargeon J, Borucki M., Black S., Dunn K. (1999).  Determinants of survival in HIV-positive patients.  Internaltional Journal of STD & AIDS, 9: 22-26.

Baillargeon J, Borucki M., Williamson J. (1999). Temporal trends in HIV-related survival.  AIDS Patient Care and STDs, 13: 17-22

Baillargeon J, Borucki M, Williamson J, Dunn K (1999).  Determinants of HIV-related survival among Texas prison inmates  AIDS Patient Care & STDs 13: 355-361.

Baillargeon J, Borucki M., Grady J. (1999).  Immunologic predictors of HIV-related survival among Texas Prison Inmates. AIDS Patient Care and STDs, 14: 183-188.

Baillargeon J, Wilkinson G. (1999) Characteristics of the Healthy Survivor Effect.  American Journal of Industrial Epidemiology, 35: 343-347.

Baillargeon J, Borucki M., Grady J. (1999) Immunologic predictors of HIV-related survival.  International Journal of STD & AIDS, 10: 467-470.

Jenson HB, Baillargeon J, Heard P, Moyer MP. (1999) Effects of tumor promoters and smokeless tobacco purified products and extracts on cell population growth and apoptosis of lymphocytes infected with Epstein-Barr virus types 1 and 2. Toxicology and Applied Pharmacology, 160: 171-182.

Baillargeon J, Wilkinson G., Rudkin L., Baillargeon G. (1998) Characteristics of the healthy worker effect: a comparison of male and female occupational cohorts.  Journal of Occupational Medicine, 40: 368-373.

Baillargeon J, Black S., Solomon D., Gugliuzza K., Dunn K. (1998).  Determinants of hemodialyysis access-related health care utilization in incarcerated and nonincarcerated populations.  Journal of Correctional Health Care. 5: 63-74.

Key Words:

cancer, leukemia, acute lymphoblastic leukemia, prostate cancer, obesity